BMS-3
|
|
|
- CAS号:
- 1338247-30-5
- 英文名:
- N-(5-(1-(2,6-dichlorophenyl)-3-(difluoroMethyl)-1H-pyrazol-5-yl)thiazol-2-yl)cyclopropanecarboxaMide
- 英文别名:
- CS-2191;BMS-3 ≥95%;BMS3;BMS 3;BMS-3;BMS-3 >=95% (HPLC);BMS-3,inhibit,Inhibitor,BMS 3,BMS3,LIMKs,LIM Kinase (LIMK);N-(5-(1-(2,6-dichlorophenyl)-3-(difluoroMethyl)-1H-pyrazol-5-yl)thiazol-2-yl)cyclopropanecarboxaMide;N-[5-[2-(2,6-dichlorophenyl)-5-(difluoromethyl)pyrazol-3-yl]-1,3-thiazol-2-yl]cyclopropanecarboxamide;N-[5-[1-(2,6-Dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl]-2-thiazolyl]-cyclopropanecarboxamide;Cyclopropanecarboxamide, N-[5-[1-(2,6-dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl]-2-thiazolyl]-
- 中文名:
- BMS-3
- 中文别名:
- 化合物BMS3;N-(5-(1-(2,6-二氯苯基)-3-(二氟甲基)-1H-吡唑-5-基)噻唑-2-基)环丙酰胺
- CBNumber:
- CB42598622
- 分子式:
- C17H12Cl2F2N4OS
- 分子量:
- 429.27
- MOL File:
- 1338247-30-5.mol
|
|
|
BMS-3化学性质
-
密度:
-
1.69±0.1 g/cm3(Predicted)
-
|
-
储存条件:
-
Sealed in dry,Store in freezer, under -20°C
-
|
-
溶解度:
-
DMF: 15 mg/ml; DMSO: 25mg/ml; DMSO:PBS (pH 7.2)(1:5): 0.2 mg/ml; Ethanol: 1 mg/ml
-
|
-
形态:
-
A crystalline solid
-
|
-
酸度系数(pKa):
-
8.28±0.70(Predicted)
-
|
BMS-3性质、用途与生产工艺
BMS-3 是一种高效的 LIMK 抑制剂，抑制 LIMK1 和 LIMK2，IC50 分别为 5 nM 和 6 nM。
|
LIMK1
5 nM (IC
50
)
|
LIMK2
6 nM (IC
50
)
|
BMS-3 (Compound 2) causes a dose-dependent reduction in cell count and induces mitotic arrest by increases in total nuclear DNA intensity and histone H3 phosphorylation after 24 h treatment in A549 human lung cancer cells. BMS-3 inhibits A549 human lung cancer cells with EC
50
value of 154 nM. BMS-3 is used to demonstrate the direct participation of LIMK1 in the phosphorylation of Cofilin. Inhibition of p-LIMK with 1-50 μM of BMS-3 results in a dose-dependent decrease of p-Cofilin after 10 min incubation in capacitating conditions. As a control, sperm are also incubated for 10 min under non-capacitating conditions which result in low levels of p-Cofilin. In the presence of 1 or 50 μM of BMS-3, actin polymerization levels are significantly lower compared to controls (DMSO). Mouse sperm are incubated under capacitating conditions for 90 min in the presence or absence of increasing concentrations of p-LIMK inhibitor BMS-3 (0, 1, 10 and 50 μM). The increasing concentrations of BMS-3 result in a strong decrease on the percentage of sperm that undergoes acrosomal exocytosis after stimulation with 20 μM of Progesterone.
BMS-3
上下游产品信息
上游原料
下游产品
1338247-30-5, BMS-3 相关搜索:
- 药靶配体
- 抑制剂
- C17H12Cl2F2N4OS
- N-(5-(1-(2,6-二氯苯基)-3-(二氟甲基)-1H-吡唑-5-基)噻唑-2-基)环丙酰胺
- 化合物BMS3
- 1338247-30-5
- BMS-3,inhibit,Inhibitor,BMS 3,BMS3,LIMKs,LIM Kinase (LIMK)
- BMS-3 >=95% (HPLC)
- Cyclopropanecarboxamide, N-[5-[1-(2,6-dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl]-2-thiazolyl]-
- BMS3;BMS 3;BMS-3
- BMS-3 ≥95%
- CS-2191
- N-[5-[2-(2,6-dichlorophenyl)-5-(difluoromethyl)pyrazol-3-yl]-1,3-thiazol-2-yl]cyclopropanecarboxamide
- N-[5-[1-(2,6-Dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl]-2-thiazolyl]-cyclopropanecarboxamide
- N-(5-(1-(2,6-dichlorophenyl)-3-(difluoroMethyl)-1H-pyrazol-5-yl)thiazol-2-yl)cyclopropanecarboxaMide